GAP Investment Advisory Board and Committee
Composed of leading members of Virginia's early-stage investment community, CIT's Investment Advisory Board (IAB) and Investment Committee guides CIT in making all GAP Tech and BioLife investment decisions.
Hiram Ewald
Managing Partner, Tall Oaks Capital
Investment Advisory Board – August 2006 to Present
GAP BioLife Investment Committee Member
Steven Ferguson
Deputy Director, Licensing and Entrepreneurship, National Institutes of Health
Investment Advisory Board – July 2011 to Present
GAP BioLife Fund Committee Member
J.S Gamble
Founder, Blu Venture Investors
Investment Advisory Board – July 2011 to Present
GAP Tech Fund Committee Member
Mike Graninger
Partner, In-Q-Tel
Investment Advisory Board – July 2011 to Present
GAP Tech Fund Committee Member
Tom Grossi
Principal, New Enterprise Associates (NEA)
Investment Advisory Board – August 2006 to Present
GAP Tech Investment Committee Member
Peter Jobse
President and CEO, Center for Innovative Technology
Investment Advisory Board – November 2003 to Present
GAP Tech, GAP BioLife & Commonwealth Energy Investment Committees Member
Lenard Marcus
Principal, Edison Ventures
Investment Advisory Board – July 2011 to Present
GAP Tech Fund Committee Member
Edmund Pendleton
Serial Entrepreneur
Investment Advisory Board – July 2011 to Present
GAP Tech Fund Committee Member
Dr. Bruce Robertson
Managing Director, H.I.G BioVentures
Investment Advisory Board – November 2003 to Present
GAP BioLife Investment Committee Member
John Uhrin
Vice President, Credit Suisse
Investment Advisory Board – January 2008 to Present
GAP BioLife Investment Committee Member
S. Tien Wong
Chief Executive Officer, Opus8
Investment Advisory Board – August 2006 to Present
GAP Tech Investment Committee Member
Past Member Organizations Include:
Carilion Biomedical Institute
Grotech Capital
Harbert Venture Partners
Intersouth Partners
New Vantage Group
Toucan Capital
Valhalla Partners